TG THERAPEUTICS, INC. Investing Cash Flow
TG THERAPEUTICS, INC. (TGTX) reported Investing Cash Flow of -$8.83 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-05
- TG THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $1.03M.
- TG THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$9.86M.
- TG THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$15.64M, a 199.05% decline year-over-year.
- TG THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $46.36M.
- TG THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2025 was $13.80M.
- TG THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2024 was -$1.04M.
- TG THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$50.65M.
- TG THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$20.01M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 13 month | Net Cash Provided by (Used in) Investing Activities 15 month | Net Cash Provided by (Used in) Investing Activities 16 month | Net Cash Provided by (Used in) Investing Activities 18 month | Net Cash Provided by (Used in) Investing Activities 19 month | Net Cash Provided by (Used in) Investing Activities 22 month | Net Cash Provided by (Used in) Investing Activities 119 month | Net Cash Provided by (Used in) Investing Activities 122 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$8.83M 10-Q · filed 2026-08-05 | -$24.47M derived: sum of 3 quarters · filed 2026-08-05 | $21.89M derived: sum of 4 quarters · filed 2026-08-05 | ||||||||
| 2026-03-31 | -$9.86M 10-Q · filed 2026-05-06 | -$25.50M derived: sum of 2 quarters · filed 2026-05-06 | $20.86M derived: sum of 3 quarters · filed 2026-05-06 | $16.87M derived: sum of 4 quarters · filed 2026-08-05 | ||||||||
| 2025-12-31 | -$15.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $30.73M derived: sum of 2 quarters · filed 2026-02-27 | $26.73M derived: sum of 3 quarters · filed 2026-08-05 | $13.80M 10-K · filed 2026-02-27 | ||||||||
| 2025-09-30 | $46.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $42.37M derived: sum of 2 quarters · filed 2026-08-05 | $29.44M 10-Q · filed 2025-11-05 | $45.23M derived: sum of 4 quarters · filed 2026-08-05 | ||||||||
| 2025-06-30 | -$3.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$16.93M 10-Q · filed 2026-08-05 | -$1.14M derived: sum of 3 quarters · filed 2026-08-05 | -$10.47M derived: sum of 4 quarters · filed 2026-08-05 | ||||||||
| 2025-03-31 | -$12.93M 10-Q · filed 2026-05-06 | $2.85M derived: sum of 2 quarters · filed 2026-05-06 | -$6.48M derived: sum of 3 quarters · filed 2026-05-06 | -$4.71M derived: sum of 4 quarters · filed 2026-05-06 | ||||||||
| 2024-12-31 | $15.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $6.45M derived: sum of 2 quarters · filed 2026-02-27 | $8.22M derived: sum of 3 quarters · filed 2026-02-27 | -$1.04M 10-K · filed 2026-02-27 | ||||||||
| 2024-09-30 | -$9.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$7.57M derived: sum of 2 quarters · filed 2025-11-05 | -$16.82M 10-Q · filed 2025-11-05 | -$61.58M derived: sum of 4 quarters · filed 2026-02-27 | ||||||||
| 2024-06-30 | $1.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$7.49M 10-Q · filed 2025-08-08 | -$52.24M derived: sum of 3 quarters · filed 2026-02-27 | -$82.47M derived: sum of 4 quarters · filed 2026-02-27 | ||||||||
| 2024-03-31 | -$9.26M 10-Q · filed 2025-05-09 | -$54.01M derived: sum of 2 quarters · filed 2026-02-27 | -$84.24M derived: sum of 3 quarters · filed 2026-02-27 | -$53.74M derived: sum of 4 quarters · filed 2026-02-27 | ||||||||
| 2023-12-31 | -$44.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$74.98M derived: sum of 2 quarters · filed 2026-02-27 | -$44.48M derived: sum of 3 quarters · filed 2026-02-27 | -$50.65M 10-K · filed 2026-02-27 | ||||||||
| 2023-09-30 | -$30.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $272.00K derived: sum of 2 quarters · filed 2024-11-07 | -$5.90M 10-Q · filed 2024-11-07 | $10.37M derived: sum of 4 quarters · filed 2025-03-03 | ||||||||
| 2023-06-30 | $30.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $24.33M 10-Q · filed 2024-08-09 | $40.60M derived: sum of 3 quarters · filed 2025-03-03 | $37.61M derived: sum of 4 quarters · filed 2025-03-03 | ||||||||
| 2023-03-31 | -$6.17M 10-Q · filed 2024-05-06 | $10.10M derived: sum of 2 quarters · filed 2025-03-03 | $7.11M derived: sum of 3 quarters · filed 2025-03-03 | $17.49M derived: sum of 4 quarters · filed 2025-03-03 | ||||||||
| 2022-12-31 | $16.27M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $13.28M derived: sum of 2 quarters · filed 2025-03-03 | $23.66M derived: sum of 3 quarters · filed 2025-03-03 | -$20.01M 10-K · filed 2025-03-03 | ||||||||
| 2022-09-30 | -$2.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $7.39M derived: sum of 2 quarters · filed 2023-11-06 | -$36.28M 10-Q · filed 2023-11-06 | -$32.99M derived: sum of 4 quarters · filed 2024-02-29 | ||||||||
| 2022-06-30 | $10.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$33.29M 10-Q · filed 2023-08-04 | -$30.00M derived: sum of 3 quarters · filed 2024-02-29 | -$30.64M derived: sum of 4 quarters · filed 2024-02-29 | ||||||||
| 2022-03-31 | -$43.67M 10-Q · filed 2023-05-08 | -$40.38M derived: sum of 2 quarters · filed 2024-02-29 | -$41.01M derived: sum of 3 quarters · filed 2024-02-29 | -$43.49M derived: sum of 4 quarters · filed 2024-02-29 | ||||||||
| 2021-12-31 | $3.29M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $2.66M derived: sum of 2 quarters · filed 2024-02-29 | $182.00K derived: sum of 3 quarters · filed 2024-02-29 | -$332.00K 10-K · filed 2024-02-29 | ||||||||
| 2021-09-30 | -$631.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$3.11M derived: sum of 2 quarters · filed 2022-11-09 | -$3.62M 10-Q · filed 2022-11-09 | -$55.70M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||
| 2021-06-30 | -$2.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$2.99M 10-Q · filed 2022-08-09 | -$55.06M derived: sum of 3 quarters · filed 2023-03-01 | -$40.15M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||
| 2021-03-31 | -$514.00K 10-Q · filed 2022-05-10 | -$52.59M derived: sum of 2 quarters · filed 2023-03-01 | -$37.68M derived: sum of 3 quarters · filed 2023-03-01 | -$26.47M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||
| 2020-12-31 | -$52.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$37.16M derived: sum of 2 quarters · filed 2023-03-01 | -$25.96M derived: sum of 3 quarters · filed 2023-03-01 | -$24.51M 10-K · filed 2023-03-01 | ||||||||
| 2020-09-30 | $14.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $26.12M derived: sum of 2 quarters · filed 2021-11-08 | $27.57M 10-Q · filed 2021-11-08 | $27.57M derived: sum of 4 quarters · filed 2022-03-01 | ||||||||
| 2020-06-30 | $11.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $12.65M 10-Q · filed 2021-08-06 | $12.66M derived: sum of 3 quarters · filed 2022-03-01 | $12.62M derived: sum of 4 quarters · filed 2022-03-01 | ||||||||
| 2020-03-31 | $1.45M 10-Q · filed 2021-05-10 | $1.45M derived: sum of 2 quarters · filed 2022-03-01 | $1.41M derived: sum of 3 quarters · filed 2022-03-01 | $1.87M derived: sum of 4 quarters · filed 2022-03-01 | ||||||||
| 2019-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$40.00K derived: sum of 2 quarters · filed 2022-03-01 | $417.00K derived: sum of 3 quarters · filed 2022-03-01 | -$718.00K 10-K · filed 2022-03-01 | ||||||||
| 2019-09-30 | -$44.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $413.00K derived: sum of 2 quarters · filed 2020-11-09 | -$722.00K 10-Q · filed 2020-11-09 | |||||||||
| 2019-06-30 | $457.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$678.00K 10-Q · filed 2020-08-10 | ||||||||||
| 2019-03-31 | -$1.14M 10-Q · filed 2020-05-11 | |||||||||||
| 2018-12-31 | $1.18M 10-K · filed 2021-03-01 | |||||||||||
| 2017-12-31 | -$8.21M 10-K · filed 2020-03-02 | |||||||||||
| 2013-09-30 | -$1.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$3.30K derived: sum of 2 quarters · filed 2013-11-14 | -$3.30K 10-Q · filed 2013-11-14 | -$3.30K derived: sum of 4 quarters · filed 2013-11-14 | $5.69K 10-Q · filed 2013-11-14 | |||||||
| 2013-06-30 | -$1.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$1.67K 10-Q · filed 2013-08-09 | -$1.67K derived: sum of 3 quarters · filed 2013-08-09 | -$1.67K derived: sum of 4 quarters · filed 2013-11-14 | $7.32K 10-Q · filed 2013-08-09 | |||||||
| 2013-03-31 | $0.00 10-Q · filed 2013-05-14 | $0.00 derived: sum of 2 quarters · filed 2013-05-14 | $0.00 derived: sum of 3 quarters · filed 2013-11-14 | -$1.40K derived: sum of 4 quarters · filed 2013-11-14 | $8.99K 10-Q · filed 2013-05-14 | |||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-21 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | -$1.40K derived: sum of 3 quarters · filed 2013-11-14 | -$1.40K 10-K · filed 2013-03-21 | $8.99K 10-K · filed 2013-03-21 | |||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$1.40K derived: sum of 2 quarters · filed 2013-11-14 | -$1.40K 10-Q · filed 2013-11-14 | $8.99K derived: sum of 4 quarters · filed 2013-11-14 | $8.99K 10-Q · filed 2012-11-14 | |||||||
| 2012-06-30 | -$1.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$1.40K 10-Q · filed 2013-08-09 | $8.99K derived: sum of 3 quarters · filed 2013-08-09 | $8.99K derived: sum of 4 quarters · filed 2013-08-09 | $8.99K 10-Q/A · filed 2012-09-07 | |||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-14 | $10.39K derived: sum of 2 quarters · filed 2013-05-14 | $10.39K derived: sum of 3 quarters · filed 2013-05-14 | $10.39K 10-Q · filed 2012-05-14 | ||||||||
| 2011-12-31 | $10.39K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-21 | $10.39K derived: sum of 2 quarters · filed 2013-03-21 | $10.39K 10-K · filed 2013-03-21 | |||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | $0.00 10-Q · filed 2012-11-14 | $886.82K 10-Q · filed 2011-11-14 | |||||||||
| 2011-06-30 | $0.00 10-Q/A · filed 2012-09-07 | $886.82K 10-Q/A · filed 2011-09-14 | ||||||||||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | $516.52K 10-Q · filed 2011-11-14 | ||||||||||
| 2010-06-30 | $516.52K 10-Q/A · filed 2011-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |